Previous work has suggested that kidney hemodialysis patients could be
at risk for either moderate copper deficiency or copper toxicity. The
present study examined copper related blood indexes in subjects under
going hemodialysis treatments with membranes that are not copper-based
, in subjects undergoing chronic ambulatory peritoneal dialysis (CAPD)
, and in control subjects. Both dialysis groups had low plasma copper
and ceruloplasmin activities. This occurred despite high plasma interl
eukin 6 concentrations, a situation that usually elevates plasma cerul
oplasmin and copper values. CAPD and hemodialysis subjects had low rat
ios of ceruloplasmin activity to immunoreactive protein, and low ratio
s of plasma copper to ceruloplasmin protein. Both are signs of copper
deficiency. In contrast, copper-containing erythrocyte superoxide dism
utase (SOD) activities were high in hemodialysis subjects and showed a
nonsignificant trend toward high values in CAPD subjects. Blood monon
uclear cell copper contents were highly variable within each group, an
d there were no significant differences between groups. In conclusion.
ceruloplasmin-related indexes in kidney dialysis patients not dialyze
d with copper-based membranes suggested a tendency toward moderate cop
per deficiency. However, this contention could not be con firmed by er
ythrocyte SOD activity or mononuclear cell copper measurements.